Daiki Ogawara

Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy

Daiki Ogawara, Hiroshi Soda, Keisuke Iwasaki et al. · Thoracic Cancer · 2017 · 38 citations · Full text

Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generating study

Hiroshi Soda, Daiki Ogawara, Yuichi Fukuda et al. · Thoracic Cancer · 2018 · 31 citations · Full text

Nivolumab Treatment, Pd-1 Blockade, Immunology +18

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara et al. · Lung Cancer · 2019 · 30 citations · Full text

Oncology, Elderly Patients, Advanced Lung Disease +9

Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum

Makoto Sumiyoshi, Hiroshi Soda, Noriaki Sadanaga et al. · Internal Medicine · 2017 · 24 citations · Full text

Xeroderma Pigmentosum, Cddp-based Chemotherapy, Medicine +10

Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4

Daiki Ogawara, Minoru Fukuda, Shiro Ueno et al. · Supportive Care in Cancer · 2015 · 19 citations · Full text

Therapeutic Drug Monitoring, Hyperthermia, Medicine +9